Licks Attorneys



Dispute resolution

Licks Attorneys is a leading Brazilian law firm recognized for handling large and complex intellectual property, life sciences, food and drug, regulatory, internet and data privacy and cyber-crime disputes. The firm is recognized for its patent disputes work with successful track records in cases on behalf of multinational pharmaceutical and agrochemical companies. The firm operates out of five offices in Rio de Janeiro, São Paulo, Brasilia, Curitiba, Brazil, and Tokyo, Japan. One client says, “Licks demonstrates a robust knowledge of the Brazilian litigation landscape, and therefore is an excellent thought partner in crafting strategy.”

The firm is led by litigation star and founding partner Otto Licks. His practice is dedicated to IP trial and appellate work, as well as complex litigation and policy work. He and new litigation star Felipe Mesquita are representing Space Data in a leading case to revive Brazilian patent application relating to a floating constellation communication system and method. Mesquita heads the Brasilia branch of the firm where he is active on patent validity, infringement, regulatory compliance, and telecommunications disputes, as well as administrative proceedings before government agencies. Clients rave about Mesquita, stating, “Felipe is gifted in crafting litigation strategy to achieve the client’s objectives. He is also extremely responsive and communicative.”

Fellow founding partner Carlos Aboim is recognized for his work in intellectual property, unfair competition, competition law and regulatory compliance cases – mainly in the areas of life sciences and information technology. He currently represents American Glass Products in an infringement lawsuit involving a patent regarding bulletproof glass after prior counsel received an ex parte preliminary injunction enjoining AGP from selling its products in Brazil, which prompted the client to seek Aboim’s representation. After the firm joined the proceeding, the appellate court overruled the trial decision a day after the appeal was filed.

Fellow founding partner Rodrigo Maior, former Federal Judge Liliane Roriz, and Otto Licks are members of the lead counsel team representing Novartis on two different lawsuits challenging the validity of a patent for the first-ever solid oral medicine for multiple sclerosis approved by the US Food and Drug Administration. The outcome of this matter has tremendous implications for the Brazilian patent system and could potentially invalidate thousands of patents in all technology areas on the same grounds. As one of the most high profile, high-stakes patent disputes in the country, this matter is based on alleged non-compliance with patentability requirements.

Founding partner Eduardo Hallak represents Gilead in defending the allowance of their patent related to sofosbuvir, the active ingredient of Sovaldi, Harvoni and Epclusa, which are cornerstone drugs in the cure for hepatitis C.